Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Feb-24 8:00 PM View:  | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Grant | 5,400 | -- | -- | < 1% 806.79K to 812.19K | |
| 14-Feb-24 8:00 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-24 | Payment of Exercise | 1,584 | $12.41 | $19,657.40 | (< 1%) 812.19K to 810.61K | |
| 06-Dec-23 8:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Dec-23 | Sale | 7,230 | $9.63 | $69,624.90 | (< 1%) 814.02K to 806.79K | |
| 05-Dec-23 9:08 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-23 | Payment of Exercise | 5,787 | $9.49 | $54,918.60 | (< 1%) 819.81K to 814.02K | |
| 14-Mar-23 6:26 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Mar-23 | Option Exercise | 27,912 | $14.00 | $390,768.00 | 3% 819.81K to 847.72K | |
| 14-Mar-23 6:26 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Mar-23 | Planned Option Sale | 27,912 | $45.16 | $1,260,630.00 | (3%) 847.72K to 819.81K | |
| 15-Feb-23 8:56 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Grant | 31,505 | -- | -- | 4% 788.3K to 819.81K | |
| 15-Feb-23 8:56 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-23 | Payment of Exercise | 20,591 | $52.77 | $1,086,590.00 | (3%) 819.81K to 799.22K | |
| 19-Dec-22 7:50 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Dec-22 | Option Exercise | 14,500 | $27.58 | $399,910.00 | 2% 773.8K to 788.3K | |
| 16-Dec-22 9:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-22 | Option Exercise | 30,000 | $14.10 | $422,907.00 | 4% 773.8K to 803.8K | |
| 16-Dec-22 9:44 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-22 | Planned Option Sale | 30,000 | $44.72 | $1,341,710.00 | (4%) 803.8K to 773.8K | |
| 05-Dec-22 7:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-22 | Payment of Exercise | 5,659 | $44.33 | $250,863.00 | (< 1%) 779.46K to 773.8K | |
| 28-Nov-22 6:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Nov-22 | Grant | 63,000 | -- | -- | 9% 716.46K to 779.46K | |
| 15-Feb-22 9:32 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Grant | 8,028 | -- | -- | 1% 710.79K to 718.82K | |
| 15-Feb-22 9:32 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-22 | Payment of Exercise | 2,355 | $62.49 | $147,164.00 | (< 1%) 718.82K to 716.46K | |
| 18-Jan-22 6:04 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Jan-22 | Option Exercise | 10,063 | $11.77 | $118,442.00 | 1% 700.73K to 710.79K | |
| 03-Dec-21 6:33 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-21 | Payment of Exercise | 1,944 | $87.68 | $170,450.00 | (< 1%) 702.67K to 700.73K | 4% |
| 23-Nov-21 7:23 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 19-Nov-21 | Grant | 25,700 | -- | -- | 4% 676.97K to 702.67K | |
| 16-Dec-20 6:20 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Dec-20 | Payment of Exercise | 2,201 | $42.52 | $93,586.50 | (< 1%) 683.69K to 681.49K | < 1% |
| 16-Dec-20 6:20 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 15-Dec-20 | Option Exercise | 7,500 | -- | -- | 1% 676.19K to 683.69K | |
| 20-Nov-20 8:21 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 20-Nov-20 | Grant | 26,500 | -- | -- | 4% 649.69K to 676.19K | |
| 18-Feb-20 6:03 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-20 | Grant | 10,395 | -- | -- | 2% 642.42K to 652.81K | |
| 18-Feb-20 6:03 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-20 | Payment of Exercise | 3,122 | $52.76 | $164,717.00 | (< 1%) 652.81K to 649.69K | 20% |
| 06-Jan-20 6:18 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-19 | Payment of Exercise | 3,330 | $63.88 | $212,720.00 | (< 1%) 645.75K to 642.42K | 34% |
| 06-Jan-20 6:18 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-Dec-19 | Option Exercise | 7,500 | -- | -- | 1% 638.25K to 645.75K | |
| 09-Oct-19 5:17 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 08-Oct-19 | Option Exercise | 7,052 | $14.18 | $99,997.40 | 1% 631.19K to 638.25K | |
| 13-Feb-19 9:16 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Grant | 50,400 | -- | -- | 8% 601.52K to 651.92K | |
| 13-Feb-19 9:16 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-19 | Payment of Exercise | 20,730 | $88.88 | $1,842,480.00 | (3%) 651.92K to 631.19K | 52% |
| 30-Jul-18 4:57 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 27-Jul-18 | Option Exercise | 8,498 | $11.77 | $99,990.00 | 1% 593.03K to 601.52K | |
| 09-Jul-18 4:56 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 06-Jul-18 | Market Sale (Planned) | 32,023 | $125.38 | $4,014,890.00 | (5%) 625.05K to 593.03K | 66% |
| 09-Jul-18 4:56 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Jul-18 | Market Sale (Planned) | 2,977 | $123.81 | $368,568.00 | (< 1%) 628.03K to 625.05K | 66% |
| 18-May-18 6:02 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 17-May-18 | Market Sale (Planned) | 10,968 | $105.83 | $1,160,740.00 | (2%) 638.99K to 628.03K | 60% |
| 18-May-18 6:02 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 16-May-18 | Market Sale (Planned) | 14,032 | $105.82 | $1,484,910.00 | (2%) 653.03K to 638.99K | 60% |
| 13-Feb-18 6:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-18 | Grant | 29,337 | -- | -- | 5% 634.82K to 664.16K | |
| 13-Feb-18 6:27 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Feb-18 | Payment of Exercise | 11,132 | $76.85 | $855,439.00 | (2%) 664.16K to 653.03K | 45% |
| 15-Feb-17 5:43 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-17 | Grant | 6,800 | -- | -- | 1% 630.3K to 637.1K | |
| 15-Feb-17 5:43 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 13-Feb-17 | Payment of Exercise | 2,278 | $29.82 | $67,918.60 | (< 1%) 637.1K to 634.82K | (42%) |
| 13-Jun-16 4:24 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 10-Jun-16 | Option Exercise | 41,645 | $2.97 | $123,848.00 | 7% 588.65K to 630.3K | |
| 10-May-16 4:43 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 10-May-16 | Option Exercise | 25,000 | $2.97 | $74,347.50 | 4% 563.65K to 588.65K | |
| 09-Mar-16 6:46 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 09-Mar-16 | Option Exercise | 18,561 | $2.54 | $47,198.80 | 3% 545.09K to 563.65K | |
| 23-Oct-15 4:13 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 23-Oct-15 | Option Exercise | 68,700 | $1.53 | $104,829.00 | 14% 476.39K to 545.09K | |
| 10-Mar-15 6:23 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 09-Mar-15 | Market Sale (Planned) | 15,000 | $33.37 | $500,521.00 | (3%) 491.39K to 476.39K | (18%) |
| 20-Feb-15 6:55 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 20-Feb-15 | Market Sale (Planned) | 15,000 | $35.35 | $530,289.00 | (3%) 506.39K to 491.39K | (11%) |
| 06-Jan-15 4:42 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 05-Jan-15 | Market Sale (Planned) | 15,000 | $50.43 | $756,463.00 | (3%) 521.39K to 506.39K | 23% |
| 15-Dec-14 8:25 AM View: | Enanta Pharmaceuticals Inc (ENTA) | 12-Dec-14 | Option Exercise | 7,055 | $0.73 | $5,169.20 | 1% 514.34K to 521.39K | |
| 02-Dec-14 4:18 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Dec-14 | Market Sale (Planned) | 15,000 | $45.39 | $680,815.00 | (3%) 529.34K to 514.34K | 14% |
| 04-Nov-14 4:52 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 03-Nov-14 | Market Sale (Planned) | 15,000 | $42.52 | $637,812.00 | (3%) 544.34K to 529.34K | 8% |
| 02-Apr-14 4:31 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 01-Apr-14 | Market Sale (Planned) | 15,000 | $39.17 | $587,542.00 | (3%) 559.34K to 544.34K | < 1% |
| 12-Mar-14 4:45 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 10-Mar-14 | Market Sale (Planned) | 10,000 | $38.49 | $384,867.00 | (2%) 569.34K to 559.34K | (1%) |
| 14-Feb-14 7:53 PM View: | Enanta Pharmaceuticals Inc (ENTA) | 14-Feb-14 | Market Sale (Planned) | 5,800 | $38.10 | $220,975.00 | (1%) 575.14K to 569.34K | (2%) |